MedTrace Logo

Study of Cryopreserved AURN001 in Subjects With Corneal Edema Secondary to Corneal Endothelial Dysfunction

NCT06630169 · Status: ACTIVE_NOT_RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2025-01-28

No results posted yet for this study

Summary

The purpose of this study is to assess the safety and efficacy of cryopreserved AURN001 in patients with corneal edema secondary to endothelial dysfunction.

Conditions

  • Corneal Edema

Interventions

COMBINATION_PRODUCT

Cryopreserved AURN001

Corneal Endothelial Cells and Y27632

Sponsors & Collaborators

  • Aurion Biotech

    lead INDUSTRY

Principal Investigators

  • Study Manager, OD · Aurion Biotech

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-09-16
Primary Completion
2025-10-31
Completion
2025-10-31

Countries

  • El Salvador

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06630169 on ClinicalTrials.gov